SCHEMBL2925531

SCHEMBL2925531

Cc1cnc(NC(=O)c2cc(Oc3ccc(C(=O)N4CCC4)cc3F)cc(OC(C)CO)c2)cn1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.79
KCNH2 Q12809 12/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2904507 1.00 GCK (0.79) GCKKCNH2
SCHEMBL2654081 0.91 GCK (0.79) GCKKCNH2
SCHEMBL2925256 0.89 GCK (1.00) GCKKCNH2
SCHEMBL2655099 0.89 GCK (1.00) GCKKCNH2
SCHEMBL2654209 0.88 GCK (0.65) GCKKCNH2
SCHEMBL2654987 0.87 GCK (0.63) GCKKCNH2
SCHEMBL2654104 0.87 GCK (0.79) GCKKCNH2
SCHEMBL2660054 0.87 GCK (0.60) GCKKCNH2
SCHEMBL2654767 0.87 GCK (0.79) GCKKCNH2
SCHEMBL4779278 0.87 GCK (0.79) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756076-B1 HETROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2010-08-11 EP disclosed